268 related articles for article (PubMed ID: 16131883)
1. Alveolar soft part sarcoma: a rare and enigmatic entity.
Anderson ME; Hornicek FJ; Gebhardt MC; Raskin KA; Mankin HJ
Clin Orthop Relat Res; 2005 Sep; 438():144-8. PubMed ID: 16131883
[TBL] [Abstract][Full Text] [Related]
2. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.
Liu YP; Jin J; Wang WH; Wang SL; Song YW; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Clin Transl Oncol; 2015 Oct; 17(10):803-9. PubMed ID: 26036854
[TBL] [Abstract][Full Text] [Related]
4. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
[TBL] [Abstract][Full Text] [Related]
5. Alveolar soft part sarcoma 'revisited': clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours.
Rekhi B; Ingle A; Agarwal M; Puri A; Laskar S; Jambhekar NA
Pathology; 2012 Jan; 44(1):11-7. PubMed ID: 22173238
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
7. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.
Orbach D; Brennan B; Casanova M; Bergeron C; Mosseri V; Francotte N; Van Noesel M; Rey A; Bisogno G; Pierron G; Ferrari A
Pediatr Blood Cancer; 2013 Nov; 60(11):1826-32. PubMed ID: 23857870
[TBL] [Abstract][Full Text] [Related]
8. Alveolar soft-part sarcoma responsive to intensive chemotherapy.
Nickerson HJ; Silberman T; Jacobsen FS; Krawisz BR; Maki HS; Arndt CA
J Pediatr Hematol Oncol; 2004 Apr; 26(4):233-5. PubMed ID: 15087950
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
10. Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M; Seitz G; von Kalle T; Vokuhl C; Scheer M; Münter M; Bielack SS; Kazanowska B; Ladenstein R; Niggli F; Klingebiel T; Fuchs J; Koscielniak E;
Pediatr Blood Cancer; 2018 Dec; 65(12):e27405. PubMed ID: 30124238
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of metastatic soft tissue sarcoma with a combination of adriamycin and DTIC or adriamycin and ifosfamide.
Weh HJ; Zügel M; Wingberg D; Schwarz R; Zornig C; Dietel M; Hossfeld DK
Onkologie; 1990 Dec; 13(6):448-52. PubMed ID: 2128712
[TBL] [Abstract][Full Text] [Related]
12. Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.
Elias A; Ryan L; Sulkes A; Collins J; Aisner J; Antman KH
J Clin Oncol; 1989 Sep; 7(9):1208-16. PubMed ID: 2504890
[TBL] [Abstract][Full Text] [Related]
13. Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients.
Pappo AS; Parham DM; Cain A; Luo X; Bowman LC; Furman WL; Rao BN; Pratt CB
Med Pediatr Oncol; 1996 Feb; 26(2):81-4. PubMed ID: 8531857
[TBL] [Abstract][Full Text] [Related]
14. Unusual gastrointestinal metastases from an alveolar soft part sarcoma.
Lee GW; Kim TH; Min HJ; Kim HJ; Jung WT; Lee OJ; Ko GH
Dig Endosc; 2010 Apr; 22(2):137-9. PubMed ID: 20447209
[TBL] [Abstract][Full Text] [Related]
15. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
16. Alveolar soft part sarcoma: Clinical presentation, treatment, and outcome in a series of 13 patients.
Lin YK; Wu PK; Chen CF; Chen CM; Tsai SW; Chih-Hsueh Chen P; Chen WM
J Chin Med Assoc; 2018 Aug; 81(8):735-741. PubMed ID: 29625801
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
18. Alveolar soft part sarcoma in Japan: multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group.
Ogose A; Yazawa Y; Ueda T; Hotta T; Kawashima H; Hatano H; Morita T;
Oncology; 2003; 65(1):7-13. PubMed ID: 12837977
[TBL] [Abstract][Full Text] [Related]
19. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Metastatic, Refractory Alveolar Soft Part Sarcoma: Case Reports and Literature Review of Treatment Options in the Era of Targeted Therapy.
Kuo DJ; Menell JS; Glade Bender JL
J Pediatr Hematol Oncol; 2016 Jul; 38(5):e169-72. PubMed ID: 27164526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
